COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,400 Articles (22,816 medRxiv, 8,584 bioRxiv)

Most recent first Previous |  Page 386: Articles 3851-3860  | Next

phuEGO: A network-based method to reconstruct active signalling pathways from phosphoproteomics datasets
Giudice, G., Chen, H., Petsalaki, E.
10.1101/2023.08.07.552249 — Posted: 2023-08-07
Purifying selection and adaptive evolution proximate to the zoonosis of SARS-CoV-1 and SARS-CoV-2
Townsend, J. P., Gaughran, S., Hassler, H. B., Fisk, J. N., Nagib, M., Wu, Y., Wang, Y., Wang, Z., Galvani, A. P., Dornburg, A.
10.1101/2023.08.07.552269 — Posted: 2023-08-07
CD4+ T cell senescence is associated with reduced reactogenicity in severe/critical COVID-19
Zhang, J., Chang, C., Liang, Z., Hu, T., Yin, Z., Liang, Y., Zhang, T., Ding, Y., Li, X., Gai, X., Yang, X., Li, X., Dong, X., Ren, J., Rao, Y., Wang, J., Yang, J., Sun, Y., Xue, L.
10.1101/2023.08.04.551565 — Posted: 2023-08-07
Influence of Prior SARS-CoV-2 Infection on COVID-19 Severity: Evidence from the National COVID Cohort Collaborative
Hendrix, N., Sidky, H., Sahner, D., N3C Consortium
10.1101/2023.08.03.23293612 — Posted: 2023-08-06
Diagnostic performance of LumiraDx SARS-CoV-2 rapid antigen test compared to PCR for diagnosis of COVID-19 in Liberia
Badio, M., Lindan, C., Johnson, K., Reilly, C., Blie, J., Shaw-Saliba, K., Fayiah, T., McCullough, J., Duworko, J. T., Higgs, E., Martin, J., Hensley, L.
10.1101/2023.08.01.23293521 — Posted: 2023-08-06
Impact of Adjustment for Differential Testing by Age and Sex on Apparent Epidemiology of SARS-CoV-2 Infection in Ontario, Canada
Bosco, S., Peng, A., Simmons, A. E., Tuite, A., Fisman, D.
10.1101/2023.08.01.23293449 — Posted: 2023-08-06
COVID-19 among migrants, refugees, and internally displaced persons: systematic review, meta-analysis and qualitative synthesis of the global empirical literature
Hintermeier, M., Gottlieb, N. D., Rohleder, S., Oppenberg, J., Baroudi, M., Pernitez-Agan, S., Lopez, J., Flores, S., Mohsenpour, A. M., Wickramage, K., Bozorgmehr, K.
10.1101/2023.08.03.23293586 — Posted: 2023-08-06
Work Attendance during Acute Respiratory Illness Before and During the COVID-19 Pandemic, United States, 2018-2022
Ahmed, F., Nowalk, M. P., Zimmerman, R., Bear, T., Grijalva, C. G., Talbot, H. K., Florea, A., Tartof, S., Gaglani, M., Smith, M. E., McLean, H. Q., King, J., Martin, E. T., Monto, A., Phillips, H., Wernli, K. J., Flannery, B., Chung, J., Uzicanin, A.
10.1101/2023.08.03.23293611 — Posted: 2023-08-06
The post-COVID-19 population has a high prevalence of crossreactive antibodies to spikes from all Orthocoronavirinae genera
Singh, G., Abbad, A., Kleiner, G., Srivastava, K., Gleason, C., Carreno Quiroz, J. M., Simon, V., Krammer, F.
10.1101/2023.08.01.23293522 — Posted: 2023-08-06
OUTCOME OF COVID-19 PATIENTS ON STEROID THERAPY: A LONGITUDINAL STUDY
Kataria, A., Bahurupi, Y., Chikara, G., Panda, P.
10.1101/2023.08.03.23293425 — Posted: 2023-08-06

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).